Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    " March 02, 2011":" April 01, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Enhancement of Connect to Protect® (C2P)
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
2 Unknown  CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements
Condition: HIV
Intervention: Dietary Supplement: Immunolin®
3 Completed Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey
Condition: HIV Infection
Intervention:
4 Completed Microparticles, Vector of Genetic Information During HIV Infection
Condition: HIV,
Intervention: Biological: Blood samples
5 Unknown  Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions
Conditions: Dating Violence;   HIV Infections
Interventions: Behavioral: Cognitive-Behavioral Dating Violence and HIV Prevention Group;   Behavioral: Psycho-educational Dating Violence and HIV prevention group
6 Completed Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: empowerment theory-based small group discussion;   Behavioral: individual resilience counseling
7 Completed Role of HIV on Glutathione Synthesis and Oxidative Stress
Conditions: HIV Infection;   Erythrocyte Glutathione Deficiency
Interventions: Dietary Supplement: Cysteine (as n-acetylcysteine) and glycine;   Dietary Supplement: Cysteine/glycine
8 Active, not recruiting The VMVN Study: Virological Monitoring in Viet Nam
Conditions: HIV Infection;   AIDS
Interventions: Other: Standard Care;   Other: Virological Monitoring
9 Unknown  Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients
Conditions: HBV Coinfection;   HIV Infections
Interventions: Drug: raltegravir and tenofovir and lamivudine;   Drug: efavirenz+tenofovir+lamivudine
10 Completed EuroSIDA As An External Comparator To MOTIVATE Trials
Conditions: HIV;   AIDS
Intervention: Other: maraviroc
11 Completed Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)
Condition: Acquired Immunodeficiency Syndrome
Intervention: Behavioral: Focus Group
12 Completed
Has Results
Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
Condition: Human Immunodeficiency Virus Infection
Intervention:
13 Completed
Has Results
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Condition: HIV-1 Infection
Interventions: Drug: FTC/RPV/TDF;   Drug: EFV/FTC/TDF
14 Completed
Has Results
A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Condition: HIV Coinfection
Interventions: Drug: Maraviroc;   Drug: Placebo
15 Completed Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Telaprevir;   Biological: pegIFN alfa-2a;   Drug: Ribavirin
16 Completed Project RAP: Family-based HIV Prevention in the Juvenile Drug Court
Condition: HIV/AIDS
Interventions: Behavioral: Family-Based HIV prevention;   Other: Adolescent Only Health Promotion
17 Completed The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study
Condition: HIV
Intervention: Drug: Maraviroc
18 Completed Drug Interactions Between Echinacea Purpurea and Etravirine
Condition: HIV
Intervention: Dietary Supplement: Echinacea purpurea
19 Completed The Raltegravir 60+ Study
Condition: HIV
Intervention: Drug: Raltegravir
20 Completed
Has Results
Levels of Raltegravir in the Female Genital Tissue
Condition: HIV
Intervention: Drug: Raltegravir

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.